Medicine and Dentistry
Non Small Cell Lung Cancer
100%
COVID-19
87%
Overall Survival
72%
Prognostic Factor
69%
Progression Free Survival
54%
Cohort Analysis
50%
Prospective Cohort Study
50%
Small Cell Lung Cancer
50%
Hazard Ratio
47%
Interstitial Lung Disease
43%
COVID-19 Vaccine
41%
Lung Cancer
39%
Retrospective Study
31%
Cumulative Incidence
30%
Idiopathic Pulmonary Fibrosis
30%
Pembrolizumab
29%
Immune Checkpoint Inhibitor
28%
Immunotherapy
26%
Docetaxel
25%
Hospital Mortality
25%
Alanine Aminotransferase
25%
Liver Metastasis
25%
Outpatient
25%
Malignant Pleural Effusion
25%
Cancer Staging
25%
Scoring System
25%
Positron Emission Tomography-Computed Tomography
25%
Autoimmunity
25%
Ustekinumab
25%
COVID-19 Vaccination
25%
Pulmonary Rehabilitation
25%
Language Processing
25%
Thromboembolism
25%
Myocarditis
25%
mRNA Vaccine
21%
Survival Rate
19%
Vitiligo
18%
Programmed Death 1 Ligand 1
16%
C Reactive Protein
15%
Dyspnea
14%
Pulmonary Edema
12%
Computer Assisted Tomography
12%
Thorax Radiography
12%
Epidermal Growth Factor Receptor
12%
Pleura Effusion
12%
Emphysema
12%
Myocardial Infarction
12%
Atrial Fibrillation
12%
Deep Vein Thrombosis
12%
Pulmonary Embolism
12%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Overall Survival
67%
Lung Cancer
61%
Cohort Study
60%
Progression Free Survival
59%
Fibrosing Alveolitis
55%
Atezolizumab
54%
Coronavirinae
50%
Small Cell Lung Cancer
50%
Prospective Cohort Study
50%
Interstitial Lung Disease
43%
Epidermal Growth Factor Receptor
37%
Pembrolizumab
29%
Immune Checkpoint Inhibitor
28%
mRNA Vaccine
27%
Hospital Mortality
25%
Cetuximab
25%
Immunotherapy
25%
Protein Tyrosine Kinase Inhibitor
25%
Mouse Model
25%
Disease Exacerbation
25%
Docetaxel
25%
Clinical Study
25%
Polyethylene Terephthalate
25%
Malignant Pleura Effusion
25%
Vedolizumab
25%
Cytotoxic Chemotherapy
25%
Cancer Staging
25%
Alanine Aminotransferase
25%
Thyroid Cancer
25%
Thromboembolism
25%
Myocarditis
25%
COVID-19 Vaccine
25%
Survival Rate
19%
Programmed Death 1 Ligand 1
16%
Breast Cancer
16%
Colorectal Carcinoma
16%
Side Effect
15%
C Reactive Protein
15%
Dyspnea
14%
Retrospective Study
14%
Neoplasm
14%
Carboplatin
13%
Lung Edema
12%
Emphysema
12%
Pleura Effusion
12%
Lung Embolism
12%
Atrial Fibrillation
12%
Heart Infarction
12%
Deep Vein Thrombosis
12%